Market Place
Sourcing Support
FluGen`s M2SR Vaccine Shows Superiority When Combined With High Dose Shot
12 Jul 2024 //
GLOBENEWSWIRE
FluGen Announces Completion of 1st Cohort in Age De-escalation Trial of M2SR
07 Sep 2022 //
PRNEWSWIRE
FluGen Begins Dosing in PIb Trial of its Intranasal M2SR Flu Vaccine
22 Jun 2022 //
PRNEWSWIRE
Naobios manufactures FluGen Inc’s M2SR influenza vaccine for clinical trials
21 Sep 2021 //
PHARMBIWEB
FluGen Awarded US DOD Fund to Study M2SR Flu Vaccine
01 Jul 2021 //
PR NEWSWIRE
FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine;1st Study in Adults Age 85
25 May 2021 //
PRNEWSWIRE
Vaccine capital: Hyderabad set to produce a third of the world`s dosage
13 Sep 2020 //
ECONOMICTIMES
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.